David Altshuler

Chief Scientific Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Vertex Pharmaceuticals Inc / Ma (VRTX)
Proxy statement

Start not stated–2026-08-01

Recorded roles and earnings-call appearances connecting this person to public companies.

VRTX

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Scientific Officer	$876,443	—	$5,250,328	—	$1,456,920	$53,787	$7,637,478
2023	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Scientific Officer	$825,000	—	$4,375,089	—	$1,299,375	$41,636	$6,541,100
2022	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Scientific Officer	$810,577	—	$4,500,090	—	$1,172,325	$42,137	$6,525,129
2021	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Scientific Officer	$756,731	—	$4,375,430	—	$1,159,200	$39,976	$6,331,337
2020	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Global Research and Chief Scientific Officer	$752,885	—	$5,250,411	—	$1,015,508	$41,780	$7,060,584

No earnings-call appearances or filed executive changes recorded yet.